Pranav Gupta
Impact in
- Oncology top 1%
- Drug Transport and Resistance Mechanisms
- Metal complexes synthesis and properties
- Molecular Biology top 5%
- Cancer therapeutics and mechanisms
Papers in
- Oncology 45
- Drug Transport and Resistance Mechanisms 36
- Chemokine receptors and signaling 6
- Metal complexes synthesis and properties 6
-
- Cancer therapeutics and mechanisms 16
- Co-authors
- Zhe‐Sheng Chen (49 shared papers)Charles R. Ashby (6 shared papers)Rishil J. Kathawala (6 shared papers)Leli Zeng (7 shared papers)Liang‐Nian Ji (1 shared paper)Enju Wang (1 shared paper)Yanglu Chen (1 shared paper)Hui Chao (1 shared paper)
- Journals
- Cancer Letters (7 papers)Cancer Research (4 papers)Molecules (3 papers)Cancers (3 papers)Oncotarget (3 papers)
- Partner nations
- United StatesChinaIndia
In The Last Decade
Pranav Gupta
75 papers receiving 3.8k citations
Pranav Gupta's Hit Papers
Peers
Comparison fields: 5 of 124
- Oncology 2.1k
- Molecular Biology 1.8k
- Organic Chemistry 702
- Cancer Research 369
- Toxicology 78
Countries citing papers authored by Pranav Gupta
This map shows the geographic impact of Pranav Gupta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pranav Gupta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pranav Gupta more than expected).
Fields of papers citing papers by Pranav Gupta
This network shows the impact of papers produced by Pranav Gupta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pranav Gupta. The network helps show where Pranav Gupta may publish in the future.
Co-authors
The 25 scholars most cited alongside Pranav Gupta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The development of anticancer ruthenium( Hit paper breakdown → | 2017 | 876 |
| 2 | The modulation of ABC transporter-mediated multidrug resistance in cancer: A review of the past decade Hit paper breakdown → | 2014 | 608 |
| 3 | Modulating ROS to overcome multidrug resistance in cancer Hit paper breakdown → | 2018 | 545 |
| 4 | 2015 | 158 | |
| 5 | 2018 | 96 | |
| 6 | 2018 | 91 | |
| 7 | 2014 | 90 | |
| 8 | 2017 | 64 | |
| 9 | 2018 | 63 | |
| 10 | 2019 | 55 | |
| 11 | 2014 | 55 | |
| 12 | 2018 | 52 | |
| 13 | 2018 | 52 | |
| 14 | 2018 | 49 | |
| 15 | 2018 | 48 | |
| 16 | 2021 | 47 | |
| 17 | 2018 | 47 | |
| 18 | 2018 | 47 | |
| 19 | 2014 | 41 | |
| 20 | 2013 | 41 |
About Pranav Gupta
Pranav Gupta is a scholar working on Oncology, Molecular Biology, Surgery, Infectious Diseases and Immunology, having authored 77 papers that have together received 3.9k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (36 papers), Cancer therapeutics and mechanisms (16 papers), HIV/AIDS drug development and treatment (13 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers), Chemokine receptors and signaling (6 papers), Metal complexes synthesis and properties (6 papers), Immunotherapy and Immune Responses (4 papers) and Pharmacological Effects and Toxicity Studies (4 papers). The work is most often cited by research in Oncology (2.1k citations), Molecular Biology (1.8k citations), Organic Chemistry (702 citations), Cancer Research (369 citations) and Toxicology (78 citations). Pranav Gupta has collaborated with scholars based in United States, China and India. Frequent co-authors include Zhe‐Sheng Chen, Charles R. Ashby, Rishil J. Kathawala, Leli Zeng, Liang‐Nian Ji, Enju Wang, Yanglu Chen, Hui Chao, Dong‐Hua Yang and Jing‐Quan Wang. Their work appears in journals such as Cancer Letters, Cancer Research, Molecules, Cancers and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.